Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Predicting Treatment Response in Patients With OCD
NCT03993535Phase 4Completed
- Sponsor
- Universidade de São Paulo
- Start
- Oct 2018
- Primary completion
- Apr 2023
- Modality
- Small Molecules
- Countries
- 4
01
Overview
A Phase 4 trial of sertraline in obsessive compulsive disorder (OCD), sponsored by Universidade de São Paulo. Started Oct 2018; status: completed.
02
Drugs
sertraline
03
Conditions
obsessive compulsive disorder (OCD)
Beyond the preview
Go deeper on NCT03993535.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03993535.